Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasm Metastasis × Therapeutics × Clear all

Status

Completed 4 Not yet recruiting 2 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma, Follicular 2 Waldenstrom Macroglobulinemia 1 Ulnar Neuropathies 1 Thrombocythemia, Essential 1 Sleep Wake Disorders 1 Sezary Syndrome 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Nurse-Patient Relations 1 Neuroma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Motor Activity 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Prolymphocytic 1

Interventions

pembrolizumab 28 Nivolumab 15 Specimen Handling 14 Paclitaxel 14 Ipilimumab 14 Magnetic Resonance Spectroscopy 12 Gemcitabine 11 Carboplatin 11 Biopsy 11 Irinotecan 10 130-nm albumin-bound paclitaxel 8 palbociclib 7 atezolizumab 7 abemaciclib 7 Radiosurgery 7 Capecitabine 7 Docetaxel 6 Albumin-Bound Paclitaxel 6 olaparib 5 durvalumab 5 avelumab 5 Pemetrexed 5 Cisplatin 5 Cetuximab 5 trastuzumab deruxtecan 4 trametinib 4 osimertinib 4 Trastuzumab 4 Radiation 4 Leucovorin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04447651 2025-07-14

PRISMM

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Active not recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡